Literature DB >> 12618186

Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.

Douglas R Davies1, Heidrun Interthal, James J Champoux, Wim G J Hol.   

Abstract

Tyrosyl-DNA phosphodiesterase (Tdp1) is a member of the phospholipase D superfamily and acts as a DNA repair enzyme that removes stalled topoisomerase I- DNA complexes by hydrolyzing the bond between a tyrosine side chain and a DNA 3' phosphate. Despite the complexity of the substrate of this phosphodiesterase, vanadate succeeded in linking human Tdp1, a tyrosine-containing peptide, and a single-stranded DNA oligonucleotide into a quaternary complex that mimics the transition state for the first step of the catalytic reaction. The conformation of the bound substrate mimic gives compelling evidence that the topoisomerase I-DNA complex must undergo extensive modification prior to cleavage by Tdp1. The structure also illustrates that the use of vanadate as the central moiety in high-order complexes has the potential to be a general method for capturing protein-substrate interactions for phosphoryl transfer enzymes, even when the substrates are large, complicated, and unusual.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618186     DOI: 10.1016/s1074-5521(03)00021-8

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  56 in total

1.  Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer.

Authors:  Chunyan Liu; Shaoyu Zhou; Shahnaz Begum; David Sidransky; William H Westra; Malcolm Brock; Joseph A Califano
Journal:  Lung Cancer       Date:  2006-11-21       Impact factor: 5.705

2.  Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.

Authors:  Karin C Nitiss; Mobeen Malik; Xiaoping He; Stephen W White; John L Nitiss
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

3.  A structural basis for allosteric control of DNA recombination by lambda integrase.

Authors:  Tapan Biswas; Hideki Aihara; Marta Radman-Livaja; David Filman; Arthur Landy; Tom Ellenberger
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

Review 4.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

5.  Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.

Authors:  Trung Xuan Nguyen; Andrew Morrell; Martin Conda-Sheridan; Christophe Marchand; Keli Agama; Alun Bermingham; Alun Bermingam; Andrew G Stephen; Adel Chergui; Alena Naumova; Robert Fisher; Barry R O'Keefe; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2012-04-26       Impact factor: 7.446

Review 6.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

Review 7.  Drugging topoisomerases: lessons and challenges.

Authors:  Yves Pommier
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

8.  Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I.

Authors:  Marc C Rideout; Amy C Raymond; Alex B Burgin
Journal:  Nucleic Acids Res       Date:  2004-08-27       Impact factor: 16.971

9.  Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores.

Authors:  Iwona E Weidlich; Thomas Dexheimer; Christophe Marchand; Smitha Antony; Yves Pommier; Marc C Nicklaus
Journal:  Bioorg Med Chem       Date:  2009-11-11       Impact factor: 3.641

10.  Repair of DNA-polypeptide crosslinks by human excision nuclease.

Authors:  Joyce T Reardon; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.